Ramy Sedhom, MD, FASCO (@ramsedhom) / X

Ramy Sedhom, MD, FASCO

5,268 posts

Ramy Sedhom, MD, FASCO

@ramsedhom

Director, Program in Geriatric Onc & Supportive Care Innovation @PC3Innovation, Assistant Professor at Penn Medicine, Oncology Section Chief at Penn Princeton

Princeton, NJ

pc3i.upenn.edu/people/ramy-se…

Joined November 2013

Pinned
Ramy Sedhom, MD, FASCO
@ramsedhom
Jan 21
Imagine 4 new anticancer drugs Pallituzumab, Geriatriximab, Symptomab, & Exercizumab hit the market. They should dominate the plenary sessions at ASCO & command billion-dollar revenue. But they don't because they're nonpharmacologic & shame on us. Read our opinion piece in
23K
Ramy Sedhom, MD, FASCO
@ramsedhom
Apr 20, 2020
Replying to @colleenmfarrell
@nytimes @washingtonpost @AppleNews - anyone care to pick up this untold story of trainees !!
Ramy Sedhom, MD, FASCO
@ramsedhom
Mar 15, 2022
Summary thoughts from my Grand Rounds today on the role of Palliative Care in Cancer: -We need to prioritize the patient experience. There is more to life than scans & death -We cannot eliminate suffering, but we can anticipate it, name it, and try to alleviate it
Ramy Sedhom, MD, FASCO
@ramsedhom
Oct 12, 2019
Replying to @pipcosper and @sarahaboualaiwi
...It’s always reviewer #2 😂 @oncology_bg @guptaarjun90 @VPrasadMDMPH
Ramy Sedhom, MD, FASCO
@ramsedhom
Apr 9, 2020
1/6 Our JCO piece @guptaarjun90 on the need to improve communication training in #medonc fellowship. Every day oncologists deliver bad news. The words we choose impact pts & caregivers. Our training does not reflect the gravity of this @tmprowell @AAHPM
ascopubs.org
The Case for Focused Palliative Care Education in Oncology Training
Ramy Sedhom, MD, FASCO
@ramsedhom
Jan 2, 2020
Title says it all: "Is everything we eat associated with cancer?" Take home point: nutritional epi evidence is weak. Cancer patients go through enough; let them enjoy food without feeling guilty or anxious HT @VPrasadMDMPH @adamcifu Medical Reversals academic.oup.com/ajcn/article/9…
Ramy Sedhom, MD, FASCO
@ramsedhom
May 20, 2022
Those in #MedEd please help amplify ASCO/ACGME are piloting THIS UPCOMING MATCH integrated training in PALLIATIVE CARE/Oncology/HEMATOLOGY Exciting opportunity for residents to consider cc: @s_brond @tmprowell @cardismith @AMalone2012 @ASCO @DianeEMeier @ElizabethPrsic
Ramy Sedhom, MD, FASCO
@ramsedhom
Apr 22, 2023
In the @JCO_ASCO‼️‼️, @ravi_b_parikh & I make the case for 🎯"Precision Palliative Care" 🎯as a pragmatic solution for a care delivery problem A 🧵 Article ascopubs.org/doi/10.1200/JC…
32K
Ramy Sedhom, MD, FASCO
@ramsedhom
Jun 3, 2024
A sad reflection as I walked through the exhibition hall of @ASCO Pictured here are humble booths (compared to Pharma exhibits) Yet, these advocacy booths do so much for patients. Often, they literally save a person or families life. I applaud @ASCO for sponsoring this
7K
Ramy Sedhom, MD, FASCO
@ramsedhom
May 16, 2024
New ASCO Guideline on Palliative Care for Patients with Cancer ascopubs.org/doi/full/10.12… 1. Early referral to SPECIALIZED PC leads to improved QOL, mood, higher likelihood of documenting EOL preferences 2. PC teams are fundamentally interdisciplinary 3. PC benefits caregivers
ascopubs.org
Palliative Care for Patients With Cancer: ASCO Guideline Update
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO...
16K
Ramy Sedhom, MD, FASCO
@ramsedhom
Jun 7, 2023
While amazed at scientific advances @ASCO, returning to clinic was a humbling reminder that pts still suffer from: --inability to afford care --transportation needs --polypharmacy --unaddressed pain --navigation --poor communication We need to raise the ceiling AND the floor
8.6K
Ramy Sedhom, MD, FASCO
@ramsedhom
Sep 19, 2023
We forget median OS for EGFR mutated lung cancer is ~3 years, >40% with grade III adverse events nejm.org/doi/full/10.10… I worry about the culture in oncology where these patients are seen every 3 months & we ignore their existential/emotional/symptom needs cc: @JackWestMD
nejm.org
Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC | NEJM
Osimertinib is a third-generation, irreversible tyrosine kinase inhibitor of the epidermal growth factor receptor (EGFR-TKI) that selectively inhibits both EGFR-TKI–sensitizing and EGFR T790M resis...
41K
Ramy Sedhom, MD, FASCO
@ramsedhom
Jun 4, 2021
Little attention to grief & bereavement in #ASCO21 ; so thank you to JCO for giving us a voice @ASCO_pubs ascopubs.org/doi/full/10.12… Our thoughts @guptaarjun90 The Case for Focused Bereavement Education in Oncology Training #pallonc #supponc
ascopubs.org
Case for Focused Bereavement Education in Oncology Training
Ramy Sedhom, MD, FASCO
@ramsedhom
Feb 13, 2022
Lessons from Encanto for Onc/PC teams: -no home (institution) is perfect -be emotionally authentic -talk about Bruno (fears/hurt) -can't ignore painful experiences -we fail when we try to b superhuman -Find strength in community *Death* can be transformative cc: @tmprowell